Efficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHD

Authors

Adelaide S. Robb, George Washington UniversityFollow
Robert L. Findling, Johns Hopkins UniversityFollow
Ann C. Childress, Center for Psychiatry and Behavioral Medicine, Las Vegas, NV
Sally A. Berry, Pfizer Inc., New York, NY
Heidi W. Belden, Pfizer Inc., New York, NY
Sharon B. Wigal, AVIDA Inc., Newport Beach, CA

Document Type

Journal Article

Publication Date

2014

Journal

Journal of Attention Disorders

APA Citation

[Epub ahead of print]

Peer Reviewed

1